The Use of Adjunctive Steroids in Central Nervous Infections

Bibliographic Details
Title: The Use of Adjunctive Steroids in Central Nervous Infections
Authors: Shalini Gundamraj, Rodrigo Hasbun
Source: Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Publisher Information: Frontiers Media S.A., 2020.
Publication Year: 2020
Collection: LCC:Microbiology
Subject Terms: meningitis, encephalitis, steroids, central nervous system infections, brain abscess, cysticercosis, Microbiology, QR1-502
More Details: Central nervous system (CNS) infections continue to be associated with significant neurological morbidity and mortality despite various existing therapies. Adjunctive steroid therapy has been employed clinically to reduce inflammation in the treatment of CNS infections across various causative pathogens. Steroid therapy can potentially improve clinical outcomes including reducing mortality rates, provide no significant benefit, or cause worsened outcomes, based on the causative agent of infection. The data on benefits or harms of adjunctive steroid therapy is not consistent in outcome or density through CNS infections, and varies based on the disease diagnosis and pathogen. We summarize the existing literature on the effects of adjunctive steroid therapy on outcome for a number of CNS infections, including bacterial meningitis, herpes simplex virus, West Nile virus, tuberculosis meningitis, cryptococcal meningitis, Angiostrongylus cantonensis, neurocysticercosis, autoimmune encephalitis, toxoplasmosis, and bacterial brain abscess. We describe that while steroid therapy is beneficial and supported in pathogens such as pneumococcal meningitis and tuberculosis, for other diseases, like Listeria monocytogenes and Cryptococcus neoformans they are associated with worse outcomes. We highlight areas of consistent and proven findings and those which need more evidence for supported beneficial clinical use of adjunctive steroid therapy.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2235-2988
10456791
Relation: https://www.frontiersin.org/articles/10.3389/fcimb.2020.592017/full; https://doaj.org/toc/2235-2988
DOI: 10.3389/fcimb.2020.592017
Access URL: https://doaj.org/article/05da50206c10456791b79e4b1bbfbd7c
Accession Number: edsdoj.05da50206c10456791b79e4b1bbfbd7c
Database: Directory of Open Access Journals
More Details
ISSN:22352988
10456791
DOI:10.3389/fcimb.2020.592017
Published in:Frontiers in Cellular and Infection Microbiology
Language:English